GERN Q2 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$882,000+2941.4% YoY

Gross Profit

$865,00098.1% margin

Operating Income

-$69M-7860.9% margin

Net Income

-$67M-7639.8% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+190.1%

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$54M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$449M

Total Liabilities

$143M

Stockholders' Equity

$307M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$882,000	$29,000	+2941.4%
Gross Profit	$865,000	$29,000	+2882.8%
Operating Income	-$69M	-$52M	-33.5%
Net Income	-$67M	-$49M	-36.9%

Revenue Segments

Revenues Before Adjustments

$890,00053%

Product

$780,00047%